Prourocare Medical Stock Performance
| PUMD Stock | USD 0.0002 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and ProUroCare Medical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ProUroCare Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, ProUroCare Medical is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:10 | Last Split Date 2008-02-14 |
1 | 10 Cheap Dividend Stocks With Fortress-Like Businesses - Barrons | 10/29/2025 |
ProUroCare | Build AI portfolio with ProUroCare Stock |
ProUroCare Medical Relative Risk vs. Return Landscape
If you would invest 0.02 in ProUroCare Medical on September 30, 2025 and sell it today you would earn a total of 0.00 from holding ProUroCare Medical or generate 0.0% return on investment over 90 days. ProUroCare Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than ProUroCare, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ProUroCare Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProUroCare Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ProUroCare Medical, and traders can use it to determine the average amount a ProUroCare Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PUMD |
Based on monthly moving average ProUroCare Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProUroCare Medical by adding ProUroCare Medical to a well-diversified portfolio.
ProUroCare Medical Fundamentals Growth
ProUroCare Stock prices reflect investors' perceptions of the future prospects and financial health of ProUroCare Medical, and ProUroCare Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProUroCare Stock performance.
| Return On Asset | -0.61 | ||||
| Current Valuation | 1.73 M | ||||
| Shares Outstanding | 18.6 M | ||||
| Price To Earning | (0.05) X | ||||
| EBITDA | (462.3 K) | ||||
| Net Income | (2.96 M) | ||||
| Cash And Equivalents | 970 | ||||
| Total Debt | 500 K | ||||
| Current Ratio | 0.06 X | ||||
| Book Value Per Share | (0.22) X | ||||
| Cash Flow From Operations | (1.12 M) | ||||
| Market Capitalization | 3.72 K | ||||
| Total Asset | 235.36 K | ||||
About ProUroCare Medical Performance
By analyzing ProUroCare Medical's fundamental ratios, stakeholders can gain valuable insights into ProUroCare Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ProUroCare Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ProUroCare Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (11.32) | (11.88) | |
| Return On Capital Employed | 0.51 | 0.53 | |
| Return On Assets | (11.32) | (11.88) | |
| Return On Equity | 0.70 | 0.73 |
Things to note about ProUroCare Medical performance evaluation
Checking the ongoing alerts about ProUroCare Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ProUroCare Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ProUroCare Medical generated a negative expected return over the last 90 days | |
| ProUroCare Medical has some characteristics of a very speculative penny stock | |
| ProUroCare Medical has a very high chance of going through financial distress in the upcoming years | |
| ProUroCare Medical currently holds 500 K in liabilities. ProUroCare Medical has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProUroCare Medical's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (2.96 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProUroCare Medical currently holds about 970 in cash with (1.12 M) of positive cash flow from operations. |
- Analyzing ProUroCare Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ProUroCare Medical's stock is overvalued or undervalued compared to its peers.
- Examining ProUroCare Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ProUroCare Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ProUroCare Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ProUroCare Medical's stock. These opinions can provide insight into ProUroCare Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ProUroCare Stock analysis
When running ProUroCare Medical's price analysis, check to measure ProUroCare Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProUroCare Medical is operating at the current time. Most of ProUroCare Medical's value examination focuses on studying past and present price action to predict the probability of ProUroCare Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProUroCare Medical's price. Additionally, you may evaluate how the addition of ProUroCare Medical to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |